Global Pricing & Market Access Director Oncology

Position: Global Pricing and Market Access Director Oncology - Commercialisation stage ADC- Lung
Location: Cambridge UK hybrid with a minimum of 3 days in office
Competitive Salary & Excellent Company Benefits

About AstraZeneca

AstraZeneca is a global science-led patient-focused biopharmaceutical company that focuses on the discovery development and commercialisation of prescription medicines for some of the worlds most serious diseases.

Oncology Business Unit

Were all here to make an impact to achieve our bold ambition of eliminating cancer as a cause of death.

In the Oncology Business Unit we relentlessly follow the science challenging the status quo to deliver more effective treatments to patients in need. Our commitment means we purposefully push back the limits of knowledge to change the practice of medicine. To ensure no patient is left behind no matter what stage of disease.

Why Join Market Access at AstraZeneca

Join a highly valued strategic team that is fundamental in realising the potential of our life-changing medicines. Its through our work that AstraZeneca is able to ensure the right access is provided to our transformative medicines.

Working with new drugs new treatment modalities new digital approaches and ever-changing environments its crucial that we remain flexible and on top of the detail. Running thinking and acting fast to make smart decisions and get the right medicines to patients at the right time.

We lead the way for the industry with our pioneering valued-based agreements and Innovative Value Strategy solutions. Its our determination and unwavering belief in the power of our medicines and the science sitting behind them that drives us to ensure their value is realised.

Inspired by our people patients and pipeline we work cross-functionally to leverage our shared skills knowledge and entrepreneurial spirit to change the way medicines are assessed and perceived and turn ambitions into reality.

Were pioneering Market Access innovations: this is the place to unlock opportunities and feed our love for the challenge. United by an unrivalled passion for patients and science and always performing at the top of our game.

What youll do

Be part of Oncology Market Access and Pricing (OMAP) team leading on indications for a commercial stage Antibody Drug Conjugate in collaboration with a broader team including P&MA and Health Economics and Payer Evidence teams at the global regional and local level. You will also work closely and in collaboration with our Joint Venture Partner on the ADC Daiichi Sankyo (DS). You will also represent OMAP on relevant Global project teams (GPTs) and where established Integrated Business Teams (IBTs) working with colleagues from brand strategy commercial regulatory R&D and clinical teams.

Responsibilities will include:

• Global Price and Market Access Strategy for lung indications and other indications as agreed.
• Develop national to regional access insights for new indications across geographies working in collaboration with AZ regional and country teams.
• Develop policy narratives to support access and reimbursement.
• Develop early value messages and claims that meet payer needs across regions and identify evidence gaps and solutions
• Revise pricing & market access strategies and value stories to optimize the value of life cycle management opportunities.
• Drive the required payer insights to ensure robust and validated price & reimbursement strategies and ensure this is up to date with market dynamics including impact of any expected environment changes
• Matrix managea cross functional team to support the development of global price and market access strategy and align with the payer evidence strategy
• Manage the evolution and sign off of price policy for new indications including innovative value strategies.
• Plan launch and commercialisation activities budget and timings to achieve global reimbursement and access
• Support country teams in launch planning and execution including pricing negotiations.
• Manage price approval for lung indications working in conjunction with Global Price Implementation and DS counterparts.
• All activities to be conducted in collaboration with DS.
• Robust pricing inputs and assumptions for investment decisions commercialisation and internal forecasts for planning.
• Provide input and guidance on Clinical Development Plans for new investment.
• Provide input and guidance on regulatory trial designs target product profiles and endpoints vs payer needs for new investment.

Essential Requirements

• Graduate degree in biomedical science business or economics or similar.

• Prior oncology therapy area expertise is essential including previous commercialisation experience

• Relevant drug development and/or commercialization experience within the pharmaceutical/medical industry.
• Knowledge of the needs and expectations of national and regional payers insurers and commercial customers in our strategic markets.
• Ability to make reasoned decisions under pressure
• Ability to take people with you and bring the best out of others
• Excellence and precision in communication: credible and persuasive

Desired Requirements

• Experience working with clinicians pharmacists and payers on evidence-based customer solutions e.g. through working with local payers in EU or commercial customers in the US.
• Experience in a commercial strategy function e.g. managed markets brand director business development director head of pricing/access.
• Experience constructing payer value stories and incorporating these into TPPs
• Experience in country or regional pharmaceutical role

Interested Apply Now!

Closing Date for Applications: COB 9 July 2025

Date Posted

Closing Date